The Worst Mistake Moderna Investors Can Make in 2023
26/11 12:00
Moderna (NASDAQ: MRNA) investors didn't need to have too much patience in the early days of the pandemic. The company brought its coronavirus vaccine candidate from drawing board to market in about nine months. And the stock climbed more than 400% in just one year....